35 years of kids’ health research,
THE KIDS RESEARCH INSTITUTE AUSTRALIA
With
Professor Jonathan Carapetis AM,
Paediatrician & Executive Director
The Kids Research Institute Australia
RESEARCH IMPACT
Filmed in Perth, Western Australia | January 2026
The Kids Research Institute Australia is one of the largest and most successful medical research institutes in Australia. The Institute has created a blueprint that brings together community, researchers, practitioners, policy makers and funders, who share our vision to improve the health and wellbeing of children through excellence in research.
The Institute is headed by leading paediatrician and infectious diseases expert Professor Jonathan Carapetis, with Founding Director Professor Fiona Stanley now Patron.
The Kids is independent and not-for-profit. The majority of funding comes from our success in winning national and international competitive research grants. They also receive significant philanthropic support from corporate Australia and the community.
In November 2025, The Kids Research Institute Australia celebrated 35 years of bold ideas, groundbreaking research, and the people who find answers to the big questions about better health outcomes for children and families.
Since his appointment in 2012, Professor Carapetis has guided The Kids through a period of significant scientific achievement, organisational growth, and increased impact — all anchored to the Institute’s vision of ensuring happy, healthy kids.
During his tenure, Professor Carapetis oversaw major advancements in child health research, including discoveries that have influenced policy and practice, such as the recent adoption of RSV vaccinations.
He led the Institute through key milestones including the transition to new headquarters at Perth Children’s Hospital, the development of the Research Reimagined strategic plan, and the creation of a new, fresh brand.
Under Professor Carapetis’ leadership, The Kids strengthened its position as a national leader in child health research, building collaborations across Australia and internationally, supporting researchers and WA families through the COVID-19 pandemic, and driving a culture that has evolved traditional models of research, to accelerate and amplify impact, for children and their families.
Also announced in November 2025, was the news that Professor Carapetis will step down as Executive Director in July 2026, after 14 years of distinguished leadership.
Source: Adapted using The Kids Research Institute Australia news stories
You Might also like
-
Pregnancy in women with chronic kidney disease
Professor Shilpanjali Jesudason is an academic nephrologist and Head of Department at the Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service, South Australia.
From 2017-2020, she was the Clinical Director of Kidney Health Australia, the peak body for patients with kidney disease. In this role she developed a passion for advancing kidney disease education in primary care.
-
Respiratory health and the microbiome in the lung environment
Dr Taylor leads the Respiratory Health Group within the Microbiome and Host Health Program. His research employs tailored techniques that allow the lung environment to be characterised to a high level of accuracy, including detailed measurements of airway microbiology (microbiome), mucus composition, and inflammation. This information is used to identify predictive markers of chronic lung disease severity as well as determine effective forms of therapy.
-
ROCK-induced early-onset bowel cancer progression
Professor Michael Samuel is a cell biologist whose research interest is in understanding how cancer mechanobiology influences the tumour microenvironment, thereby promoting tumour progression. He is Professor of Matrix Biology at the University of South Australia, Adelaide and heads the Tumour Microenvironment Laboratory at the Centre for Cancer Biology and the Cancer Mechanotherapies Laboratory at the Basil Hetzel Institute for Translational Health Research.